Cardiovascular Systems reported $-4593000 in EBITDA for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 2840M 589M
Atricure ATRC:US $ -13.76M 2.27M
Baxter International BAX:US $ 743M 0M
Becton, Dickinson and BDX:US $ 1410M 457M
Boston Scientific BSX:US $ 444M 98M
Cardiovascular Systems CSII:US $ -4.59M 5.93M
Dexcom DXCM:US $ 66.8M 68.8M
Edwards Lifesciences EW:US $ 391M 2.4M
Genmark Diagnostics GNMK:US $ -0.46M 1.15M
Globus Medical GMED:US $ 71.89M 5.53M
Hologic HOLX:US $ 878.9M 105.4M
Inogen INGN:US $ 0.44M 0.19M
Insulet PODD:US $ 29.1M 10.7M
Johnson & Johnson JNJ:US $ 9474.4M 2992.4M
Medtronic MDT:US $ 2571M 289M
Merit Medical Systems MMSI:US $ 26.62M 21.68M
Nuvasive NUVA:US $ 54.36M 9.06M
Resmed RMD:US $ 263.41M 7.56M
Stryker SYK:US $ 866M 458M
Tandem Diabetes Care TNDM:US $ 0.25M 21.84M
Teleflex TFX:US $ 178.87M 22.58M
Terumo 4543:JP Y 36722M 10245M